IGF1 and hydrops fetalis: Combined data showed that patients with intermediate IGF-1 levels had a lower risk of mortality due to HF compared to those with low IGF-1 levels (RR 0.98; 95% CI 0.97–0.99; p < 0.01) (Table S9 and Figure 2).